Skip to main content
. 2020 Jun 8;10:9239. doi: 10.1038/s41598-020-66197-1

Figure 2.

Figure 2

ROC curve for the XmaI-RRBS and MSRE-PCR methods comparison (a) and evaluation of a two-gene (IRF4 and C1QL2) system for the prediction of luminal B breast cancer response to NACT by ROC analysis with 100x repeated 5−fold cross-validation (b).